Skip to content
Open access

Agnuside against spatial learning and memory deficits in a mouse model of vascular dementia

Sep 2026 · Journal of International Medical Research · Vol 54 · 0 citations · 31 references
Medicine

TL;DR

Evidence is provided that Agnuside serves as a potential therapeutic candidate for vascular dementia through modulation of angiogenesis-related genes and activation of AKT/ERK signaling.

Abstract

Objective Vascular dementia is the second most common cause of cognitive impairment in older adults, yet effective pharmacological treatments remain limited. Agnuside, a naturally occurring compound with antioxidant and anti-inflammatory properties, has shown vascular-protective potential; however, its role in vascular dementia remains unclear. Methods A mouse model of permanent bilateral common carotid artery occlusion was established to evaluate the effects of Agnuside. Cognitive function was assessed using the Morris water maze. Cerebral blood flow, tissue injury, and hippocampal cornu ammonis 1 neuronal apoptosis were evaluated using laser speckle imaging, triphenyltetrazolium chloride staining, Nissl staining, and terminal deoxynucleotidyl transferase dUTP nick-end labeling. Transcriptomic and pathway enrichment analyses were performed, and key targets were validated using quantitative real-time polymerase chain reaction and Western blotting. Results Agnuside improved spatial learning and memory, increased cerebral blood flow, reduced histopathological damage, and decreased neuronal apoptosis. Angiogenesis-related genes (Mmp3, IL1RN, and ALAS2) were differentially expressed, and selected genes were validated using quantitative real-time polymerase chain reaction. The PI3K-AKT and MAPK pathways were significantly enriched, and Agnuside restored AKT and ERK1/2 phosphorylation. Conclusions Agnuside exerts neurovascular protective effects in mice with vascular dementia, likely through modulation of angiogenesis-related genes and activation of AKT/ERK signaling. These findings provide evidence that Agnuside serves as a potential therapeutic candidate for vascular dementia.

Read PDF

Similar papers

2026

Rosemary inhalation improves the behavior and cognition of vascular cognitive impairment rats by regulating SIRT1/mTOR pathway-mediated cell apoptosis and autophagy

Rosemary inhalation can improve behavior and cognition in VCI rats by regulating SIRT1/mTOR pathway-mediated cell apoptosis and autophagy and intervention with EX527 attenuated this protective effect.

Feng-Fei Shi, En-Si Hong, Jie-Wei Bao et al. · 0 citations
Oct 2026

Maresin1 Improves Angiogenesis and Cognitive Function by Regulating Perivascular Macrophages in Rats with Chronic Cerebral Hypoperfusion

It is demonstrated that IGF-1/p-Akt/VEGF pathway activation in pvMΦ plays a crucial role in Maresin1-mediated angiogenesis in CCH rats, and the increased VEGF expression was predominantly mediated by perivascular macrophage (pvMΦ) activation.

Hao Song, Miao-Yu Du, Hao-Ying He et al. · 0 citations
Open access Oct 2026

EXPRESS: Longitudinal Quantitative MRI of Blood-Brain Barrier Leakage in Chronic Cerebral Hypoperfusion Rat model.

Objective-Methods:Chronic cerebral-hypoperfusion is a key contributor to vascular cognitive impairment, with blood-brain barrier (BBB) dysfunction proposed as an early driver of white matter injury. The temporal-evolution and regional-heterogeneity of BBB-leakage remain poorly characterized in vivo. We longitudinally a...

Ana Sampedro-Viana, Sabela Fernández-Rodicio, José Castillo et al. · 0 citations
Review Open access Oct 2026

“Morphological, Functional, and Molecular Progression of Blood-Brain Barrier Dysfunction in Alzheimer’s Disease”

Blood-brain barrier (BBB) dysfunction is increasingly recognized as an early pathological event in sporadic Alzheimer’s disease (AD), which represents over 95% of cases. Vascular risk factors and cerebral insulin resistance are considered potential contributors to its initiation. This review synthesizes evidence availa...

Karen León-Arcia, Humberto Martínez-Orozco, Magdalena Guerra-Crespo et al. · 0 citations
Open access Oct 2026

Fraxetin Ameliorates Cognitive Impairment in STZ-Induced Mice: Involvement of Suppressed Microglial Hyperactivation and Improved Mitochondrial Dysfunction

Therapeutic for Alzheimer’s disease (AD) remains a pressing medical challenge in the field of neuroscience. Natural compounds with structural diversity and multi-target regulatory properties have attracted increasing attention for the treatment of complex neurodegenerative disorders. Fraxetin, previously identified thr...

Jun Zhao, Yi-Ming Bai, Chao Wang et al. · 0 citations
Open access Oct 2026

Modified Dioscorea pills ameliorate cognitive impairment induced by chronic cerebral hypoperfusion via restoring the hippocampal neurovascular unit

Chronic cerebral hypoperfusion (CCH) is a major cause of progressive cognitive decline and vascular dementia in older adults. Modified Dioscorea Pills (MDP), a traditional Chinese medicinal formula, has demonstrated clinical efficacy for dementia treatment. However, the effects and molecular mechanisms of MDP on th...

Qian Xu, Dan He, Hong-Bing Li · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.